Florez Lab/Twitter
May 3, 2024, 11:59
Florez Lab – Tweetorial on Young-onset lung cancer
Florez Lab shared a post on X:
“Young-onset lung cancer is a rising concern, with epidemiological trends showing high incidence.
Early detection and individualized, targeted treatments are key to achieving superior outcomes.
Ready for a deep dive into Young Lung Cancer? Let’s go!
Patients with Young Lung Cancer are a distinct subgroup. In a cohort of young NSCLC patients <50 years, two-thirds of patients presented at advanced clinical stage (67% at Stage IV).
Lung cancer in never-smokers has increased, especially in women and younger age groups. Research findings:
121 pts <40yrs at dx
73% → never smoked
90% → adenocarcinoma;
Patients with oncogenic mutations (ALK, RET, ROS) likely to be younger at diagnosis.”
Source: Florez Lab/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 14:06
Dec 21, 2024, 13:46
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33